Skip to main content
. Author manuscript; available in PMC: 2019 Apr 26.
Published in final edited form as: Health Technol Assess. 2018 Feb;22(10):1–104. doi: 10.3310/hta22100

Table 8. Seizure types experienced by participants in the 2 years preceding their enrolment in the EpAID trial.

Seizure type Treatment arm
Active
 TAU
n/N % n/N %
Absence 56/174 32.2 26/105 24.8
Atonic 24/174 13.8 9/105 8.6
Tonic 36/174 20.7 20/105 19.0
Clonic 5/174 2.9 4/105 3.8
Tonic–clonic 153/174 87.9 86/105 81.9
Simple partial (focal) 27/174 15.5 5/104 4.8
Complex partial (focal) 80/174 46.0 32/104 30.8
Myoclonic 23/174 13.2 26/105 24.8
Drop attacks 11/174 6.3 11/105 10.5